ReviewExpert opinion on investigational drugs2016
Investigational histone deacetylase inhibitors (HDACi) in myeloproliferative neoplasms.
Prithviraj Bose et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papertrialcites it